These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 23149064)

  • 1. Decrease in health-related quality of life associated with awareness of hepatitis C virus infection among people who inject drugs in Scotland.
    McDonald SA; Hutchinson SJ; Palmateer NE; Allen E; Cameron SO; Goldberg DJ; Taylor A
    J Hepatol; 2013 Mar; 58(3):460-6. PubMed ID: 23149064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health-related quality of life in active injecting drug users with and without chronic hepatitis C virus infection.
    Dalgard O; Egeland A; Skaug K; Vilimas K; Steen T
    Hepatology; 2004 Jan; 39(1):74-80. PubMed ID: 14752825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between harm reduction intervention uptake and recent hepatitis C infection among people who inject drugs attending sites that provide sterile injecting equipment in Scotland.
    Allen EJ; Palmateer NE; Hutchinson SJ; Cameron S; Goldberg DJ; Taylor A
    Int J Drug Policy; 2012 Sep; 23(5):346-52. PubMed ID: 22940142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic hepatitis C virus infection: does it really impact health-related quality of life? A study in rural Egypt.
    Schwarzinger M; Dewedar S; Rekacewicz C; Abd Elaziz KM; Fontanet A; Carrat F; Mohamed MK
    Hepatology; 2004 Dec; 40(6):1434-41. PubMed ID: 15565610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved health-related quality of life after hepatitis C viraemic clearance among people who inject drugs may not be durable.
    McDonald SA; Myring G; Palmateer NE; McAuley A; Beer L; Dillon JF; Hollingworth W; Gunson R; Hickman M; Hutchinson SJ
    Addiction; 2023 Jul; 118(7):1340-1350. PubMed ID: 36808787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of hepatitis C antiviral effectiveness awareness among people who inject drugs in the direct-acting antiviral era.
    Valerio H; McAuley A; Innes H; Palmateer N; Goldberg DJ; Munro A; Taylor A; Hutchinson SJ
    Int J Drug Policy; 2018 Feb; 52():115-122. PubMed ID: 29414462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does informing people who inject drugs of their hepatitis C status influence their injecting behaviour? Analysis of the Networks II study.
    Aspinall EJ; Weir A; Sacks-Davis R; Spelman T; Grebely J; Higgs P; Hutchinson SJ; Hellard ME
    Int J Drug Policy; 2014 Jan; 25(1):179-82. PubMed ID: 24315504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B virus exposure and vaccination in a cohort of people who inject drugs: what has been the impact of targeted free vaccination?
    Winter RJ; Dietze PM; Gouillou M; Hellard ME; Robinson P; Aitken CK
    J Gastroenterol Hepatol; 2013 Feb; 28(2):314-22. PubMed ID: 23190264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recommendations for the management of hepatitis C virus infection among people who inject drugs.
    Robaeys G; Grebely J; Mauss S; Bruggmann P; Moussalli J; De Gottardi A; Swan T; Arain A; Kautz A; Stöver H; Wedemeyer H; Schaefer M; Taylor L; Backmund M; Dalgard O; Prins M; Dore GJ;
    Clin Infect Dis; 2013 Aug; 57 Suppl 2():S129-37. PubMed ID: 23884061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment and treatment of hepatitis C virus infection among people who inject drugs in the opioid substitution setting: ETHOS study.
    Alavi M; Grebely J; Micallef M; Dunlop AJ; Balcomb AC; Day CA; Treloar C; Bath N; Haber PS; Dore GJ;
    Clin Infect Dis; 2013 Aug; 57 Suppl 2():S62-9. PubMed ID: 23884068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of hepatitis C in an ethnically diverse HIV-1-infected cohort in south London.
    Mohsen AH; Murad S; Easterbrook PJ
    HIV Med; 2005 May; 6(3):206-15. PubMed ID: 15876288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis.
    Foster GR; Goldin RD; Thomas HC
    Hepatology; 1998 Jan; 27(1):209-12. PubMed ID: 9425939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uptake of hepatitis C treatment among people who inject drugs attending Needle and Syringe Programs in Australia, 1999-2011.
    Iversen J; Grebely J; Topp L; Wand H; Dore G; Maher L
    J Viral Hepat; 2014 Mar; 21(3):198-207. PubMed ID: 24438681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concordance between self-reported and actual hepatitis C virus infection status in a cohort of people who inject drugs.
    O'Keefe D; Aitken C; Higgs P; Dietze P
    Drug Alcohol Rev; 2013 Mar; 32(2):208-10. PubMed ID: 22943595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in access to care among injection drug users infected either with HIV and hepatitis C or hepatitis C alone.
    Braitstein P; Li K; Kerr T; Montaner JS; Hogg RS; Wood E
    AIDS Care; 2006 Oct; 18(7):690-3. PubMed ID: 16971276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of diagnosis of hepatitis C virus on quality of life.
    Rodger AJ; Jolley D; Thompson SC; Lanigan A; Crofts N
    Hepatology; 1999 Nov; 30(5):1299-301. PubMed ID: 10534353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychopathological changes and quality of life in hepatitis C virus-infected, opioid-dependent patients during maintenance therapy.
    Schäfer A; Wittchen HU; Backmund M; Soyka M; Gölz J; Siegert J; Schäfer M; Tretter F; Kraus MR
    Addiction; 2009 Apr; 104(4):630-40. PubMed ID: 19335661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with awareness of infection status among chronic hepatitis B and C carriers in Korea.
    Shin A; Cho ER; Kim J; Sung J; Park KW; Lim MK; Shin HR
    Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1894-8. PubMed ID: 19454614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depression and protective factors of mental health in people with hepatitis C: a questionnaire survey.
    Erim Y; Tagay S; Beckmann M; Bein S; Cicinnati V; Beckebaum S; Senf W; Schlaak JF
    Int J Nurs Stud; 2010 Mar; 47(3):342-9. PubMed ID: 19766994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained drug use changes after hepatitis C screening and counseling among recently infected persons who inject drugs: a longitudinal study.
    Bruneau J; Zang G; Abrahamowicz M; Jutras-Aswad D; Daniel M; Roy E
    Clin Infect Dis; 2014 Mar; 58(6):755-61. PubMed ID: 24363333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.